Background: As a result of low-dose ionizing radiation exposure during clinical practice, female orthopaedic surgeons may be at increased risk for breast cancer. Methods: The 2009 American Academy of Orthopaedic Surgeons (AAOS) membership directory was used to mail a survey to all female AAOS fellows. Survey responses were collected between June 2009 and June 2010 among 505 (69.7%) of the eligible women. We calculated standardized prevalence ratios (SPRs) and 95% confidence intervals (CIs) by dividing the observed number of cancers among female orthopaedic surgeons by the expected number, based on the gender-specific, age-specific, and race-specific cancer prevalence statistics in the general U.S. population. We compared the distribution of breast cancer risk factors in our study population to that of the women in the 2007 California Health Interview Survey (CHIS, n = 30,541). Results: Twenty-four women reported a prior diagnosis of invasive cancer. Female orthopaedic surgeons had a prevalence of cancer that was 85% higher than that of the general U.S. female population (SPR 1.85, 95% CI 1.19-2.76). Orthopaedic surgeons in our study also had a statistically significant 2.9-fold higher prevalence of breast cancer compared to the general U.S. female population (SPR 2.9, 95% CI 1.66-4.71). Survey respondents had a higher prevalence of both protective and predisposing breast cancer factors compared to California women. Conclusions: Our findings confirm that breast cancer prevalence is elevated among female orthopaedic surgeons. Although further research is needed to determine the factors behind this population's hypothesized increased risk, taken together, our results and others suggest that the orthopaedic community consider educating current practitioners of the use of protective shielding and other modifiable breast cancer risk factors.
Introduction
W ith exposure to low-dose ionizing radiation and polymethylmethacrylate (PMMA) during fluoroscopy and joint replacement procedures, respectively, orthopaedic surgeons may be at increased risk for certain cancers. 1, 2 We have reported previously that the prevalence of cancers among female orthopaedic surgeons practicing in the United States was 1.9-fold higher than that of women in the general U.S. population. 3 We further hypothesized that this would also be the case for breast cancer in particular, given that ionizing radiation exposure at higher doses is an established breast cancer risk factor. 4, 5 In support of this hypothesis, we reported a higher prevalence of breast cancer among female orthopaedic surgeons compared to estimates from women in the general U.S. population. 3 Although suggestive, several notable limitations demanded cautious interpretation of our results. For example, one possible explanation for our previous findings was that female orthopaedic surgeons may be at increased risk of breast cancer because they tend to exhibit reproductive characteristics that are known risk factors for breast cancer, such as having children later in life or having fewer children. In addition, our previous study did not collect self-reported data on race/ ethnicity, a strong risk breast cancer risk factor, 6 thus requiring estimation from external sources to calculate race/ethnicityadjusted statistics. We addressed these limitations is a newly designed and conducted study described here.
The primary objectives of the current study were to determine if cancer risk factors among female orthopaedic surgeons differ from those of the general population and to provide estimates for the age-adjusted and race-adjusted cancer (all and breast) prevalence of female orthopaedic surgeons compared with the general U.S. population. The study objectives were accomplished by collecting information from female orthopaedic surgeons on cancer diagnoses, selfreported race/ethnicity, breast cancer risk factors (e.g., menstrual and reproductive factors, use of exogenous hormones, history of mammography), and details relating to type of clinical practice and frequency of fluoroscopy use.
Materials and Methods

Survey methods
The 2009 American Academy of Orthopaedic Surgeons (AAOS) membership directory was used to obtain the names and mailing addresses of all female AAOS fellows. We identified 757 potentially eligible AAOS fellows. Each one was mailed a cover letter explaining the purpose of the study, a survey, and a stamped return-addressed envelope. Survey responses were collected between June 2009 and June 2010. Responses from 33 individuals indicated that they were either male (20) or not orthopaedic surgeons (3) or were otherwise ineligible for the study (10) . Of the remaining 724 eligible individuals, 505 (69.7%) participated in the study by mailing back the survey.
Participants were asked to provide information about their age, race/ethnicity, subspecialty, years in practice, and type of practice, as well as their current in-office use of fluoroscopy, x-rays, PMMA, and lead protection. Information related to body size, smoking history, menstrual and reproductive history, use of hormones, mammography, and alcohol use was also collected. History of cancer diagnoses was assessed solely by self-report with the following questions: Have you had cancer? What type(s) of cancer? and When were you first diagnosed with cancer? All study activities were approved by the Stanford School of Medicine Institutional Review Board.
Statistical analysis
We compared the distribution of breast cancer risk factors in our study population to that of the women in the 2007 and 2009 California Health Interview Surveys (CHIS). 7, 8 The CHIS is a population-based, random-digit dial telephone survey of California's noninstitutionalized population. 9 The CHIS adult surveys include questions related to women's health, such as age at menarche, number of births, age at first birth, hormone replacement therapy (HRT) use, and mammography use. 10, 11 Our analyses of cancer prevalence were limited to all melanomas and invasive internal cancers diagnosed in female orthopaedic surgeons within 17 years of the survey date ( ‡ 1993), This 17-year cutoff was introduced to keep our results comparable to the 17-year, limited-duration prevalence statistics collected by the National Cancer Institute's (NCI) Surveillance Epidemiology and End Results (SEER 11) program. 12 Prevalence statistics from SEER include new and preexisting cases for people alive on a certain date. 13 We excluded 3 diagnoses of basal cell and squamous cell skin cancer (also excluded from SEER statistics) and 5 other cancers (of the thyroid, kidney, and cervix and melanoma) that were diagnosed between 1973 and 1991 from our study population. We compared the prevalence of cancer by surrogates for occupational radiation exposure, including type of subspecialty, frequency of fluoroscopy use, and use of protective shielding. Subspecialties were categorized into two groups: those with a hypothesized increased frequency of imaging thick bony or muscular areas, and thus greater opportunity of radiation exposure (e.g., general, trauma, oncology, spine, and shoulder), and all other subspecialties. The NCI's Breast Cancer Assessment Tool (i.e., the Gail Model) 14 was used to estimate the lifetime breast cancer risk among a representative woman within our study population. 
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We calculated standardized prevalence ratios (SPRs) by dividing the observed number of cancers among female orthopaedic surgeons by the expected number, based on the gender-specific, age-specific (10-year groups), and racespecific cancer prevalences in the general U.S. population. For example, the expected number of cases is calculated by multiplying the prevalence rate of each gender-age-race cell by the number of people in our sample in each cell and then summing. Although having small numbers or zero values in some 8 Alcohol consumption frequency was pulled from the CHIS 2007 survey, among women ‡ 32 years (n = 27,289). 7 We restricted the CHIS datasets to women ‡ 32 years for better comparability with our study population. cells causes no problems with this method, exact statistics were calculated. Confidence intervals (CIs) and exact p values were calculated by assuming a Poisson distribution for the observed number of cases and using an approximation to the exact Poisson test. 15 Although this method is more commonly applied to standardized mortality ratios, it nonetheless provides an accurate test of whether the SPR departs from unity when > 10 cases are observed. 16, 17 Considering that women without a history of cancer may have been less likely to participate in our study, we performed sensitivity analyses to evaluate the influence of potential response bias on our main results. We calculated SPRs and 95% CIs with the following assumptions: (1) that all nonrespondents had no history of cancer and (2) that nonrespondents experienced the same cancer prevalence as the general U.S. population.
Results
Survey respondents practiced an average of 21 years, primarily in the private or academic setting, and most frequently subspecialized in general or hand surgery (Table 1) . Most surgeons in our study population first used fluoroscopy when they were in their mid-20s to early 30s (Table 1) . There was a wide range in the frequency of standard and minifluoroscopy use, and 73% of the surgeons reported using standard x-rays less than once per month. Among the 60% of respondents who use PMMA in their practice, most used it more than once a month (Table 1) . Over 93% of surgeons reported regularly using protective shielding in the operating room. Using published estimates of radiation exposure to orthopaedic surgeons while performing fluoroscopy (between 10 and 15 millirem per case), 18, 19 we estimated a cumulative exposure between 1,725 and 13,703 millirem among our study population based on their frequency of standard fluoroscopy and minifluoroscopy use and average duration of clinical practice.
We compared the prevalence of breast cancer risk factors among female orthopaedic surgeons to that of a large population-based sample of California women 9 and to U.S. women 20 ( Table 2 ). In terms of protective factors, women in our study population were somewhat younger and more likely to be of white race/ethnicity compared to women in California. Additionally, the orthopaedic surgeons in our study population were also more likely than their California counterparts to have a normal body mass index (BMI) ( < 25.0 kg/m 2 ) and to be never smokers. In terms of hormone-related breast cancer risk factors, respondents had an older age at menarche and used menopausal hormones for shorter durations compared to California women. Although 60% of the surgeons had given birth at least once, they were also more likely to have their first child at or after age 30 ( Table 2) .
Twenty-nine women reported a prior diagnosis of invasive cancer (n = 24) or carcinoma in situ (CIS) (n = 5) ( Table 3 ). There was a statistically nonsignificant difference in the prevalence of invasive cancer by subspecialty category, where there was a 6.5% prevalence among surgeons with a subspecialty that was likely to have higher radiation exposure (e.g., general, trauma, oncology, spine, and shoulder) compared with a 3.9% prevalence among surgeons with all other subspecialties ( p = 0.2). 
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Similar differences in cancer prevalence were observed by frequency of standard fluoroscopy use ( Table 4 ). The prevalence of invasive cancer was similar by frequency of minifluoroscopy, use of PMMA, and protective shielding use (Table 4) . Female orthopaedic surgeons had a prevalence of cancer that was 85% higher than that of the age-adjusted and raceadjusted general US female population (Table 5) . Orthopaedic surgeons in our study also had a statistically significant 2.9-fold higher prevalence of breast cancer, compared to the ageadjusted and race-adjusted general US female population (Table 5 ). This statistically significant increase in cancer prevalence among female orthopaedic surgeons remained when we restricted our study population to surgeons who were currently practicing (Table 5 ). Using the Gail Model, 14 we estimated that the lifetime breast cancer risk was 10.5% for a hypothetical woman who represented the characteristics of our study population (e.g., white race/ethnicity, 46 years of age, no family history, no medical history of ductal or lobular CIS, started menstruating at age 12 years, and had no births). In comparison, a woman's lifetime risk of breast cancer is 12.3%, based on US rates from 2006-2008. 21 In sensitivity analyses, SPRs and corresponding 95% CIs were calculated under the assumption that nonrespondents had the same age and race/ethnicity distribution as respondents. Breast cancer prevalence remained over 2-fold higher among orthopaedic surgeons compared to the general U.S. population regardless of assumptions about cancer prevalence among the nonrespondents. The SPR was 2.02 (95% CI 1.15-3.28) under the assumption that there were no breast cancer cases among the nonrespondents and 2.33 (95% CI 1.39-3.66) under the assumption that nonrespondents had the same number of breast cancer cases as would be expected among the general U.S. female population (e.g., n = 5.52). In sensitivity analyses for overall cancer prevalence, the SPR was 1.6 (95% CI 1.07-2.29) when nonrespondents were assumed to have population expected cancer rates and 1.48 (95% CI 0.94-2.20) when respondents were assumed to have no history of cancer.
Discussion
Using data collected from a new sample of 505 AAOS female orthopaedic surgeons in the United States, we report a statistically significant higher cancer prevalence for all cancers (SPR 1.85) and for breast cancer (SPR 2.90) among female orthopaedic surgeons compared to women in the general U.S. population. Survey respondents had a higher prevalence of both protective and predisposing breast cancer factors compared to California women. In terms of protective factors, female orthopaedic surgeons were more likely to have a normal BMI, were less likely to smoke, and were less likely to use menopausal HRT for > 4 years compared to the CHIS population. 22 Although a similar percentage of women in both groups, the orthopaedic surgeons and the CHIS population, had reported ever having had a mammogram, 42% of the orthopaedic surgeons had their first mammogram before age 40. Both early age at first mammography and the relatively young mean age of our study population may have contributed to the earlier average age of diagnosis in our study population compared to the general U.S. female population. Alternatively, our findings could also suggest the presence of a communal risk factor or combination of risk factors that may predispose female orthopaedic surgeons to early onset of disease.
On the other hand, female orthopaedic surgeons also had a higher frequency for other established breast cancer risk factors compared to California women. Respondents were less likely to abstain from alcohol consumption, although only 55% of female orthopaedic surgeons reported the consumption of more than 1 drink per week compared to 66% of the CHIS population. The most striking and likely the most significant predisposing risk factor lies in the reproductive status of this cohort. Compared to the CHIS population, the orthopaedic surgeons were more likely to be nulliparous (39% vs. 18%), and among those who had given birth, the surgeons were likely to have had their first child after the age of 30 (83% vs. 20%). In the U.S. population, the total fertility rate or number of children per women is 2.1, and the average age at first birth is 25 years. 20 Older age at first birth is a breast cancer risk factor that has been identified previously within other surgical populations. [23] [24] [25] Surgical PMMA, standard fluoroscopy, and minifluoroscopy use varied greatly among female orthopaedic surgeons, although the majority of respondents reported the use of some form of fluoroscopy in their practice: 97.4% use standard fluoroscopy and 90.7% use minifluoroscopy during an average year. Multiple studies in female medical radiology technologists have demonstrated an elevated risk of developing breast cancer. [26] [27] [28] Doody et al. 29 demonstrated a moderately lower breast cancer risk for female radiology technologists who reported apron or shield use when they began working before 1950, > 93% of female orthopaedic surgeons in our study reported use of protective shielding, with 80.4% reporting use > 75% of the time. However, only 42.2% of respondents reported use of a thyroid shield. Because of the small number of breast cancer cases in our study population, regression analyses between protective practices and cancer history were not performed. Multiple studies have linked ionizing radiation exposure to an elevated risk of developing thyroid cancer. 30, 31 Several studies have looked at the effects of repeated exposure to ionizing radiation in radiology technologists, radiologists, and interventional cardiologists and have found that radiation exposure is decreasing in this population as a result of education about exposure prevention and improved radiologic technology. 29, 32, 33 However, preventive education is not common in nonregulated specialties, such as orthopaedic surgery.
The strengths of our study include the response of nearly 70% of the surgeons contacted for participation, suggesting that selection bias is not a likely explanation for our observed findings. Additionally, we conducted sensitivity analyses that demonstrated similar SPR values regardless of our assumptions about breast cancer rates among nonrespondents. Limitations of our study include the sole use of self-reported breast cancer diagnoses, as well as the absence of information on whether the mammograms sought before age 40 were performed to follow up symptoms or for elective screening. Our findings support the notion that female orthopaedic surgeons are at higher risk of breast cancer compared to the general U.S. female population. 3 A likely contributory factor to the higher prevalence of breast cancer may be exposure to ionizing radiation as well as PMMA use. We were able to show that several known cancer risk factors, such as BMI, tobacco consumption, and HRT use, were not likely contributors to the higher prevalence, given their lower frequency in the surgeon population compared to the frequency among California women. It is very likely, however, that the higher breast cancer prevalence among female orthopaedic surgeons is due in part to delayed childbearing and having few children. Additionally, several recent studies among nurses working night shifts have shown positive associations between working night shifts and risk of breast cancer, 34, 35 supporting a hypothesis that the disruption of circadian rhythm is a breast cancer risk factor. 36 The frequency of night shift work among orthopaedic surgeons while on-call may contribute to their higher breast cancer prevalence compared to the general U.S. population. Our findings confirm that cancer prevalence, and breast cancer especially, is elevated among female orthopaedic surgeons. Although further research is needed to determine the factors behind this population's hypothesized increased risk, taken together, our results and others suggest that the orthopaedic community consider educating current practitioners in the use of protective shielding and other modifiable breast cancer risk factors, such as alcohol consumption.
